393 related articles for article (PubMed ID: 24953865)
1. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators.
Park WS; Ryu J; Cho KH; Choi MK; Moon SH; Yun T; Chun BS; Lee GK; Ahn HJ; Lee JH; Vermeer P; Jung YS
Head Neck; 2012 Oct; 34(10):1408-17. PubMed ID: 22052559
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
4. CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma.
Toyoda M; Kaira K; Shino M; Sakakura K; Takahashi K; Takayasu Y; Tominaga H; Oriuchi N; Nikkuni O; Suzuki M; Iijima M; Tsukamoto N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
Head Neck; 2015 Nov; 37(11):1569-74. PubMed ID: 24913970
[TBL] [Abstract][Full Text] [Related]
5. Effect of time to simulation and treatment for patients with oropharyngeal cancer receiving definitive radiotherapy in the era of risk stratification using smoking and human papillomavirus status.
Amsbaugh MJ; Yusuf M; Cash E; Silverman C; Potts K; Dunlap N
Head Neck; 2018 Apr; 40(4):687-695. PubMed ID: 29356189
[TBL] [Abstract][Full Text] [Related]
6. Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Hawkins PG; Mierzwa ML; Bellile E; Jackson WC; Malloy KM; Chinn SB; Spector ME; Shuman AG; Stucken CL; McLean SA; Bradford CR; Prince ME; Carey TE; Worden FP; Swiecicki PL; Taylor JMG; Wolf GT; Eisbruch A; Casper KA
Head Neck; 2019 Apr; 41(4):857-864. PubMed ID: 30775826
[TBL] [Abstract][Full Text] [Related]
7. Poor prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomas that overexpress hypoxia inducible factor-1α.
Swartz JE; Pothen AJ; van Kempen PM; Stegeman I; Formsma FK; Cann EM; Willems SM; Grolman W
Head Neck; 2016 Sep; 38(9):1338-46. PubMed ID: 27027530
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Nguyen TV; Bova RJ; Kench JG; Cole IE; Musgrove EA; Henshall SM; Sutherland RL
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3705-11. PubMed ID: 14506162
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1-a prognostic marker in oropharyngeal squamous cell carcinoma that is tightly associated with high-risk human papillomavirus status.
Scantlebury JB; Luo J; Thorstad WL; El-Mofty SK; Lewis JS
Hum Pathol; 2013 Aug; 44(8):1672-80. PubMed ID: 23566410
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma.
Huber GF; Albinger-Hegyi A; Soltermann A; Roessle M; Graf N; Haerle SK; Holzmann D; Moch H; Hegyi I
Cancer; 2011 Oct; 117(20):4659-70. PubMed ID: 21448927
[TBL] [Abstract][Full Text] [Related]
12. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.
Andrews G; Lango M; Cohen R; Feigenberg S; Burtness B; Mehra R; Ahmed S; Nicolaou N; Gaughan J; Ridge JA
Head Neck; 2011 Oct; 33(10):1433-40. PubMed ID: 21928415
[TBL] [Abstract][Full Text] [Related]
13. Presence of human papillomaviruses and p16 expression in hypopharyngeal cancer.
Wendt M; Romanitan M; Näsman A; Dalianis T; Hammarstedt L; Marklund L; Ramqvist T; Munck-Wikland E
Head Neck; 2014 Jan; 36(1):107-12. PubMed ID: 23737140
[TBL] [Abstract][Full Text] [Related]
14. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Importance of Comorbidity and the Association Between Comorbidity and p16 in Oropharyngeal Squamous Cell Carcinoma.
Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):568-75. PubMed ID: 27077485
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell anaplasia and multinucleation are predictors of disease recurrence in oropharyngeal squamous cell carcinoma, including among just the human papillomavirus-related cancers.
Lewis JS; Scantlebury JB; Luo J; Thorstad WL
Am J Surg Pathol; 2012 Jul; 36(7):1036-46. PubMed ID: 22743286
[TBL] [Abstract][Full Text] [Related]
17. Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status.
Kumar B; Yadav A; Brown NV; Zhao S; Cipolla MJ; Wakely PE; Schmitt AC; Baiocchi RA; Teknos TN; Old M; Kumar P
Oncotarget; 2017 Feb; 8(9):14847-14859. PubMed ID: 28107179
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.
Perisanidis C; Perisanidis B; Wrba F; Brandstetter A; El Gazzar S; Papadogeorgakis N; Seemann R; Ewers R; Kyzas PA; Filipits M
J Oral Pathol Med; 2012 Jan; 41(1):40-6. PubMed ID: 21883486
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
[TBL] [Abstract][Full Text] [Related]
20. Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
Lee J; Chang JS; Kwon HJ; Kim SH; Shin SJ; Keum KC
Jpn J Clin Oncol; 2016 Oct; 46(10):911-918. PubMed ID: 27474125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
